for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

MEDNAX Inc

MD

Latest Trade

20.52USD

Change

0.31(+1.53%)

Volume

173,477

Today's Range

20.40

 - 

21.06

52 Week Range

7.37

 - 

28.66

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Mednax Q3 Loss Per Share $0.49

Nov 6 (Reuters) - MEDNAX Inc <MD.N>::MEDNAX REPORTS THIRD QUARTER RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $0.37 FROM CONTINUING OPERATIONS.Q3 LOSS PER SHARE $0.03 FROM CONTINUING OPERATIONS.Q3 LOSS PER SHARE $0.49.Q3 REVENUE $461 MILLION VERSUS REFINITIV IBES ESTIMATE OF $535.4 MILLION.Q3 SAME STORE SALES FELL 0.4 PERCENT.Q3 EARNINGS PER SHARE ESTIMATE $0.40 -- REFINITIV IBES DATA.

Mednax Announces Agreement To Sell Mednax Radiology Solutions To Radiology Partners

Sept 10 (Reuters) - MEDNAX Inc <MD.N>::PRESS RELEASE - MEDNAX ANNOUNCES AGREEMENT TO SELL MEDNAX RADIOLOGY SOLUTIONS TO RADIOLOGY PARTNERS.MEDNAX INC- DEAL FOR $885 MILLION.MEDNAX INC - WILL REPORT OPERATING RESULTS OF MEDNAX RADIOLOGY SOLUTIONS AS DISCONTINUED OPERATIONS.MEDNAX INC - DOES NOT ANTICIPATE THAT THERE WILL BE ANY MATERIAL TAX IMPACT TO PROCEEDS.

Mednax Reports Second Quarter Results

July 30 (Reuters) - MEDNAX Inc <MD.N>::MEDNAX REPORTS SECOND QUARTER RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.32 FROM CONTINUING OPERATIONS.Q2 EARNINGS PER SHARE $0.09 FROM CONTINUING OPERATIONS.Q2 LOSS PER SHARE $8.03.Q2 REVENUE $509 MILLION VERSUS REFINITIV IBES ESTIMATE OF $555.9 MILLION.Q2 SAME STORE SALES FELL 11.7 PERCENT.Q2 EARNINGS PER SHARE ESTIMATE $0.09 -- REFINITIV IBES DATA.MAINTAINING ITS OUTLOOK FOR INITIAL FINANCIAL PROFILE OF PEDIATRIX MEDICAL GROUP PROVIDED AS PART OF ITS INVESTOR PRESENTATION ON JUNE 5T.DURING 2020 Q2, CO'S OPERATIONS WERE SIGNIFICANTLY IMPACTED BY REDUCTIONS IN PATIENT VOLUMES AND REVENUE.SAME-UNIT REVENUE ATTRIBUTABLE TO PATIENT VOLUME DECREASED BY 11.9 PERCENT FOR 2020 Q2.

Mednax Says Guy Sansone Appointed Chair Of Board Of Directors

July 13 (Reuters) - MEDNAX Inc <MD.N>::MEDNAX INC - GUY P. SANSONE APPOINTED CHAIR OF BOARD OF DIRECTORS.MEDNAX INC - MARK S. ORDAN APPOINTED CHIEF EXECUTIVE OFFICER, SUCCEEDING COMPANY FOUNDER ROGER J. MEDEL, M.D..MEDNAX INC - REACHES AGREEMENT WITH STARBOARD VALUE.MEDNAX INC - BOARD HAS APPOINTED FIVE NEW DIRECTORS.MEDNAX INC - STARBOARD HAS WITHDRAWN ITS DIRECTOR NOMINATIONS PREVIOUSLY SUBMITTED TO COMPANY.MEDNAX - DIRECTORS CESAR L. ALVAREZ, MICHAEL B. FERNANDEZ, PASCAL J. GOLDSCHMIDT, M.D., CARLOS A. MIGOYA AND ENRIQUE J. SOSA, STEPPED DOWN FROM BOARD.MEDNAX INC - STARBOARD AGREED TO SUPPORT BOARD'S FULL SLATE OF DIRECTORS AT COMPANY'S 2020 ANNUAL MEETING.

Mednax Reports Significant Progress In Strategic Transformation

June 5 (Reuters) - MEDNAX Inc <MD.N>::MEDNAX ANNOUNCES SIGNIFICANT PROGRESS IN STRATEGIC TRANSFORMATION.MEDNAX INC - REPAYS REVOLVING LINE OF CREDIT AND PROVIDES BUSINESS UPDAT.MEDNAX INC - ANNOUNCES INTENT TO SELL MEDNAX RADIOLOGY SOLUTIONS.MEDNAX - INTENDS TO RETURN TO ITS ORIGINAL COMPANY NAME, PEDIATRIX MEDICAL GROUP, INC PENDING APPROVAL BY SHAREHOLDERS AT ANNUAL MEETING IN AUGUST.MEDNAX INC - INTENDS TO APPLY PROCEEDS FROM A SALE OF MEDNAX RADIOLOGY SOLUTIONS TOWARDS DEBT REDUCTION.MEDNAX - DURING 2020 Q2 TO DATE OPERATIONS HAVE BEEN SIGNIFICANTLY IMPACTED BY REDUCTIONS IN PATIENT VOLUMES, REVENUE DUE TO COVID-19 PANDEMIC.MEDNAX INC - CO'S OPERATIONS BEGAN TO NORMALIZE IN AN ACCELERATING FASHION DURING MONTH OF MAY.MEDNAX INC - IN RADIOLOGY SERVICES MEDICAL GROUP, DURING APRIL, STUDY VOLUMES DECLINED BY ABOUT 50% VERSUS PRIOR YEAR.MEDNAX - IN OFFICE-BASED WOMEN'S AND CHILDREN'S MEDICAL GROUPS, DURING APRIL, PATIENT VOLUMES DECLINED BY ABOUT 25% VERSUS PRIOR YEAR.MEDNAX - IN TOTAL, ESTIMATES REDUCTION TO CONSOLIDATED REVENUE DUE TO DECLINES IN PATIENT VOLUME DURING MAY, VERSUS PRIOR YEAR , WAS IN RANGE OF ABOUT 10%-15%.

Starboard Value LP Raises Share Stake In Box Inc and Mednax Inc

May 15 (Reuters) - Starboard Value LP::STARBOARD VALUE LP RAISES SHARE STAKE IN BOX INC BY 60.5% TO 11.67 MILLION CLASS A SHARES - SEC FILING.STARBOARD VALUE LP TAKES SHARE STAKE IN GREEN DOT CORP OF 4.96 MILLION CLASS A SHARES.STARBOARD VALUE LP TAKES SHARE STAKE IN RESIDEO TECHNOLOGIES INC OF 2.62 MILLION COMMON SHARES.STARBOARD VALUE LP RAISES SHARE STAKE IN MEDNAX INC TO 7.9 MILLION COMMON SHARES FROM 3.9 MILLION COMMON SHARES.STARBOARD VALUE LP - CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2020 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DECEMBER 31, 2019.

Mednax Reports Q1 Adjusted Earnings Per Share $0.32

May 7 (Reuters) - MEDNAX Inc <MD.N>::MEDNAX REPORTS FIRST QUARTER RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.32 FROM CONTINUING OPERATIONS.Q1 LOSS PER SHARE $0.20 FROM CONTINUING OPERATIONS.Q1 REVENUE $846 MILLION VERSUS REFINITIV IBES ESTIMATE OF $852.4 MILLION.Q1 SAME STORE SALES FELL 1 PERCENT.Q1 EARNINGS PER SHARE ESTIMATE $0.54 -- REFINITIV IBES DATA.OPERATING RESULTS FOR Q1 WERE SIGNIFICANTLY IMPACTED BY REDUCTIONS IN PATIENT VOLUMES AND REVENUE.MEDNAX - ESTIMATES REDUCTION TO REVENUES DUE TO DECLINES IN PATIENT VOLUME DURING APRIL, AS COMPARED TO PRIOR YEAR, WAS IN RANGE OF 30 TO 35 PERCENT.WITHDRAWAL OF PRELIMINARY FULL YEAR OUTLOOK FOR 2020 DUE TO COVID-19 IMPACT.

MEDNAX Executives Take Temporary Reductions In Cash Compensation

April 7 (Reuters) - MEDNAX Inc <MD.N>::BOARD, NAMED EXECUTIVE OFFICERS, OTHER MEMBERS OF SENIOR LEADERSHIP AGREED TO VARIOUS TEMPORARY REDUCTIONS IN CASH COMPENSATION.MEMBERS OF BOARD AGREED TO FOREGO ANNUAL CASH RETAINER & CASH MEETING PAYMENTS UNTIL SUCH FEES ARE REINSTATED.STEPHEN D. FARBER, CFO, AGREED TO FOREGO 50% OF ANNUAL BASE SALARY FOR PERIOD APRIL 1 THROUGH JUNE 30.

MEDNAX Reports Q4 Adjusted Earnings Per Share Of $0.91

Feb 20 (Reuters) - Mednax Inc <MD.N>::MEDNAX REPORTS FOURTH QUARTER RESULTS.SEES Q1 2020 ADJUSTED EARNINGS PER SHARE $0.55 TO $0.63.Q4 ADJUSTED EARNINGS PER SHARE $0.91 FROM CONTINUING OPERATIONS.Q4 EARNINGS PER SHARE $0.40 FROM CONTINUING OPERATIONS.Q4 REVENUE $905 MILLION VERSUS REFINITIV IBES ESTIMATE OF $901.2 MILLION.Q4 SAME STORE SALES ROSE 2.3 PERCENT.Q4 EARNINGS PER SHARE ESTIMATE $0.90 -- REFINITIV IBES DATA.SAYS ANNOUNCES MULTI-STATE, UNILATERAL TERMINATION BY UNITEDHEALTH GROUP.MEDNAX - RECEIVED NOTIFICATION BY ENTITIES AFFILIATED WITH UNITEDHEALTH GROUP THAT CONTRACTS OF CO'S AFFILIATED PRACTICES ACROSS FOUR STATES, UNILATERALLY TERMINATED.SAYS GIVEN UNPRECEDENTED NATURE OF ACTIONS, MEDNAX CANNOT ESTIMATE IMPACT OF SURPRISE TERMINATIONS.SAYS DISAPPOINTED THAT UNITED WOULD TAKE SUCH ACTION TO UNILATERALLY TERMINATE AFFILIATED PRACTICES FROM ITS NETWORKS.SAYS TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDED MARCH 31, 2020 WILL BE IN A RANGE OF TWO TO FOUR PERCENT.SAYS Q1 OUTLOOK DOES NOT INCLUDE ANY POTENTIAL IMPACT FROM ANNOUNCED CONTRACT TERMINATIONS INITIATED BY UNITEDHEALTH.SAYS NOT ABLE TO FORECAST OUTCOME OF CONTRACT TERMINATIONS INITIATED BY UNITEDHEALTH, NOR ESTIMATE POTENTIAL IMPACT TO ITS RESULTS.SEES 2020 ADJUSTED EBITDA, WITH RANGE OF BETWEEN $450 MILLION AND $490 MILLION.SAYS 2020 OUTLOOK DOES NOT INCLUDE ANY POTENTIAL IMPACT FROM ANNOUNCED CONTRACT TERMINATIONS INITIATED BY UNITEDHEALTH.

Starboard Value Lp Reports 7.5% Stake In Mednax Inc As Of February 4, 2020 - SEC Filing

Feb 13 (Reuters) - MEDNAX Inc <MD.N>::STARBOARD VALUE LP REPORTS 7.5% STAKE IN MEDNAX INC AS OF FEBRUARY 4, 2020 - SEC FILING.STARBOARD VALUE LP SAYS PURCHASED MEDNAX INC SHARES BASED BELIEF THAT SHARES, WHEN PURCHASED, WERE "UNDERVALUED".STARBOARD VALUE LP - ON NOV 27, 2019, DELIVERED LETTER TO MEDNAX INC NOMINATING A SLATE OF EIGHT DIRECTOR CANDIDATES.STARBOARD VALUE LP - ENGAGED, TO CONTINUE TO ENGAGE, IN DISCUSSIONS WITH MEDNAX MANAGEMENT, BOARD REGARDING BOARD REPRESENTATION, COMPOSITION OF BOARD.STARBOARD VALUE - TO FILE PRELIMINARY PROXY STATEMENT, WITH U.S. SEC TO BE USED TO SOLICIT VOTES FOR ELECTION OF STARBOARD’S NOMINEES AT MEDNAX AGM.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up